DNAJB1 and Hypoglycemia: For example, HSPA8 was lower at 1-h (988.2 ± 29.8 vs 1127.0 ± 49.1 RFU of HSPA8, 1-h post-hypoglycemia vs baseline, p < 0.01) (Fig. 4E); DNAJB1 was lower at 0.5 and 1-h (337.4 ± 13.7 vs 404.2 ± 23.2 RFU of DNAJB1, 0.5-h post-hypoglycemia vs baseline, p < 0.05; 338.8 ± 14.4 vs 404.2 ± 23.2 RFU of DNAJB1, 1-h post-hypoglycemia vs baseline, p < 0.05 (Fig. 4F).